✦ LIBER ✦

77: Safety and Immunogenicity of a Novel Hepatitis B Vaccine Adjuvanted With Immunostimulatory Sequence (ISS) in Renal Predialysis and Dialyis Patients

✍ Scribed by Alberdina W. de Boer; Shelly McNeil; Scott A. Halperin; Randy Hart; Mark A. Miller; Mark Lipman; Steven D. Soroka; J. Tyler Martin Sr

Book ID: 114469642
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 84 KB
Volume: 55
Category: Article
ISSN: 0272-6386
DOI: 10.1053/j.ajkd.2010.02.084

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

154 Immunogenicity and safety of a novel

154 Immunogenicity and safety of a novel adjuvanted hepatitis B candidate vaccine in liver transplant patients

✍ F. Nevens; J.N. Zuckerman; A. Burroughs; M.C. Jung; J.M. Bayas; B. Kallinowski; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Safety and immunogenicity of a hepatitis

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

✍ S. Thoelen; P. Van Damme; C. Mathei; G. Leroux-Roels; I. Desombere; A. Safary; P 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 794 KB

Immunogenicity and safety of an adjuvant

Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients

✍ CHIEW TONG, NORELLA KONG; BERAN, JIRI; KEE, SWEE ANN; MIGUEL, JOSE LUIS; SÁNCHEZ 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 82 KB

Safety and immunogenicity of hepatitis A

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

✍ Emmet B. Keeffe; Sten Iwarson; Brian J. McMahon; Karen L. Lindsay; Raymond S. Ko 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

Acute hepatitis A superimposed on chronic liver disease (CLD) has been associated with severe or fulminant hepatitis. An open, multicenter study was performed to compare the safety and immunogenicity of an inactivated hepatitis A vaccine in patients with CLD with that in healthy subjects. A secondar

Immunogenicity and safety of an investig

Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease

✍ Janssen, Robert S.; Mangoo-Karim, Roberto; Pergola, Pablo E.; Girndt, Matthias; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 961 KB

Comparison of the safety and immunogenic

Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults

✍ Scott A. Halperin; Simon Dobson; Shelly McNeil; Joanne M. Langley; Bruce Smith; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 130 KB